215 related articles for article (PubMed ID: 23909855)
1. Proposal for a "phase II" multicenter trial model for preclinical new antiepilepsy therapy development.
O'Brien TJ; Ben-Menachem E; Bertram EH; Collins SD; Kokaia M; Lerche H; Klitgaard H; Staley KJ; Vaudano E; Walker MC; Simonato M
Epilepsia; 2013 Aug; 54 Suppl 4():70-4. PubMed ID: 23909855
[TBL] [Abstract][Full Text] [Related]
2. Development of new treatment approaches for epilepsy: unmet needs and opportunities.
French JA; White HS; Klitgaard H; Holmes GL; Privitera MD; Cole AJ; Quay E; Wiebe S; Schmidt D; Porter RJ; Arzimanoglou A; Trinka E; Perucca E
Epilepsia; 2013 Aug; 54 Suppl 4():3-12. PubMed ID: 23909849
[TBL] [Abstract][Full Text] [Related]
3. Epilepsy therapy development: technical and methodologic issues in studies with animal models.
Galanopoulou AS; Kokaia M; Loeb JA; Nehlig A; Pitkänen A; Rogawski MA; Staley KJ; Whittemore VH; Dudek FE
Epilepsia; 2013 Aug; 54 Suppl 4(0 4):13-23. PubMed ID: 23909850
[TBL] [Abstract][Full Text] [Related]
4. Epilepsy biomarkers.
Engel J; Pitkänen A; Loeb JA; Dudek FE; Bertram EH; Cole AJ; Moshé SL; Wiebe S; Jensen FE; Mody I; Nehlig A; Vezzani A
Epilepsia; 2013 Aug; 54 Suppl 4(0 4):61-9. PubMed ID: 23909854
[TBL] [Abstract][Full Text] [Related]
5. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.
Privitera M
Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139
[TBL] [Abstract][Full Text] [Related]
6. Development of new antiepileptic drugs: challenges, incentives, and recent advances.
Perucca E; French J; Bialer M
Lancet Neurol; 2007 Sep; 6(9):793-804. PubMed ID: 17706563
[TBL] [Abstract][Full Text] [Related]
7. European investigational antiepilepsy drug trials.
Sussman NM
Epilepsy Res Suppl; 1993; 10():149-55. PubMed ID: 8251090
[No Abstract] [Full Text] [Related]
8. Issues related to development of antiepileptogenic therapies.
Pitkänen A; Nehlig A; Brooks-Kayal AR; Dudek FE; Friedman D; Galanopoulou AS; Jensen FE; Kaminski RM; Kapur J; Klitgaard H; Löscher W; Mody I; Schmidt D
Epilepsia; 2013 Aug; 54 Suppl 4(0 4):35-43. PubMed ID: 23909852
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitor (TKI)-induced cardiotoxicity: approaches to narrow the gaps between preclinical safety evaluation and clinical outcome.
Yang B; Papoian T
J Appl Toxicol; 2012 Dec; 32(12):945-51. PubMed ID: 22961481
[TBL] [Abstract][Full Text] [Related]
10. Carisbamate, a new carbamate for the treatment of epilepsy.
Kulig K; Malawska B
IDrugs; 2007 Oct; 10(10):720-7. PubMed ID: 17899491
[TBL] [Abstract][Full Text] [Related]
11. Epothilone D (Kosan/Roche).
Kolman A
Curr Opin Investig Drugs; 2004 Jun; 5(6):657-67. PubMed ID: 15242255
[TBL] [Abstract][Full Text] [Related]
12. New drugs for pediatric epilepsy.
Chu-Shore CJ; Thiele EA
Semin Pediatr Neurol; 2010 Dec; 17(4):214-23. PubMed ID: 21183127
[TBL] [Abstract][Full Text] [Related]
13. When clinical trials make history: demonstrating efficacy of new antiepileptic drugs as monotherapy.
Perucca E
Epilepsia; 2010 Oct; 51(10):1933-5. PubMed ID: 20491875
[TBL] [Abstract][Full Text] [Related]
14. Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure.
Fox SH; Lang AE; Brotchie JM
Mov Disord; 2006 Oct; 21(10):1578-94. PubMed ID: 16874752
[TBL] [Abstract][Full Text] [Related]
15. Making the investigational oncology pipeline more efficient and effective: are we headed in the right direction?
LoRusso PM; Anderson AB; Boerner SA; Averbuch SD
Clin Cancer Res; 2010 Dec; 16(24):5956-62. PubMed ID: 21169248
[TBL] [Abstract][Full Text] [Related]
16. Emerging drugs for focal epilepsy.
Mula M
Expert Opin Emerg Drugs; 2013 Mar; 18(1):87-95. PubMed ID: 23176519
[TBL] [Abstract][Full Text] [Related]
17. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
18. Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II.
Nagoshi N; Fehlings MG
Expert Opin Investig Drugs; 2015 May; 24(5):645-58. PubMed ID: 25645889
[TBL] [Abstract][Full Text] [Related]
19. [The new antiepileptic drugs: their indications and side effects].
Malagón-Valdez J
Rev Neurol; 2004 Sep 16-30; 39(6):570-5. PubMed ID: 15467997
[TBL] [Abstract][Full Text] [Related]
20. Eterobarb.
Wolter KD
Epilepsy Res Suppl; 1991; 3():99-102. PubMed ID: 1777088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
